Neurological disorders presenting mainly in adolescence

Macleod, S.; Appleton, R. E.
February 2007
Archives of Disease in Childhood;Feb2007, Vol. 92 Issue 2, p170
Academic Journal
The aim of this review is to discuss some of the neurological diseases that present mainly in the adolescent period. The article focuses on the usual presentation and course of the more common, and some uncommon, epilepsies, neuromuscular disorders, neurodegenerative disorders, inflammatory disorders of the central nervous system and some other, miscellaneous conditions. The article ends with a very brief and general discussion about management issues in this age group.


Related Articles

  • Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Solomon, Andrew J; Spain, Rebecca I; Kruer, Michael C; Bourdette, Dennis // Multiple Sclerosis Journal;Dec2011, Vol. 17 Issue 12, p1472 

    Background: TNF alpha inhibitor (TNFAI) therapy has been associated with inflammatory neurological syndromes.Objectives: To present 10 new cases of TNFAI associated neurological disease and a review of the literature.Methods: The design and methods were based on case series collected from Oregon...

  • Immunological Approaches to Prevent Neuronal Apoptosis During Neuroinflammation. Murphy, F. J.; Keating, K. E.; Sheehan, D.; Hayes, I. // Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy A;Aug2005, Vol. 4 Issue 4, p367 

    Neurodegeneration is set to increase in parallel with society's age demographics. With the increasing appreciation of the role played by apoptosis in neurodegeneration, much effort has gone into understanding key effectors in this process and to develop therapies that reduce neuronal apoptosis,...

  • Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado–Joseph disease. Chun-Feng Tan; Yamada, Mitsunori; Toyoshima, Yasuko; Yokoseki, Akio; Miki, Yukari; Hoshi, Yasuhiro; Kaneko, Hiroyuki; Ikeuchi, Takeshi; Onodera, Osamu; Kakita, Akiyoshi; Takahashi, Hitoshi // Acta Neuropathologica;Oct2009, Vol. 118 Issue 4, p553 

    Pathological transactivation-responsive DNA-binding protein 43 (TDP-43) has been identified as a component of ubiquitinated inclusions in frontotemporal lobar degeneration with motor neuron disease, as well as in sporadic and some forms of familial amyotrophic lateral sclerosis. To clarify...

  • Systemic AAV6 Delivery Mediating RNA Interference Against SOD1: Neuromuscular Transduction Does Not Alter Disease Progression in fALS Mice. Towne, Chris; Raoul, Cédric; Schneider, Bernard L.; A.ebischer, Patrick // Molecular Therapy;Jun2008, Vol. 16 Issue 6, p1018 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder arising from the selective death of motor neurons. Approximately 20% of familial ALS (fALS) cases are caused by toxic gain-of-function mutations in the superoxide dismutase 1 (SOD1) gene. We as well as others have provided...

  • Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity. Dodge, James C.; Haidet, Amanda M.; Yang, Wendy; Passini, Marco A.; Hester, Mark; Clarke, Jennifer; Roskelley, Eric M.; Treleaven, Christopher M.; Rizo, Liza; Martin, Heather; Kim, Soo H.; Kaspar, Rita; Taksir, Tatyana V.; Griffiths, Denise A.; Cheng, Seng H.; Shihabuddin, Lamya S.; Kaspar, Brian K. // Molecular Therapy;Jun2008, Vol. 16 Issue 6, p1056 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor system. Recent work in rodent models of ALS has shown that insulin-like growth factor-1 (IGF-1) slows disease progression when delivered at disease onset. However, IGF-1's mechanism of action along the...

  • The human G93A-SOD1 mutation in a presymptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression. Jokic, Natasa; Yip, Ping K.; Michael-Titus, Adina; Priestley, John V.; Malaspina, Andrea // BMC Genomics;2010, Vol. 11, p633 

    Background: Traumatic injuries can undermine neurological functions and act as risk factors for the development of irreversible and fatal neurodegenerative disorders like amyotrophic lateral sclerosis (ALS). In this study, we have investigated how a mutation of the superoxide dismutase 1 (SOD1)...

  • Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation. Kaushik, Deepak K.; Gupta, Malvika; Das, Sulagna; Basu, Anirban // Journal of Neuroinflammation;2010, Vol. 7, p68 

    Background: Activation of microglia, the resident macrophages of the central nervous system (CNS), is the hallmark of neuroinflammation in neurodegenerative diseases and other pathological conditions associated with CNS infection. The activation of microglia is often associated with bystander...

  • Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes. Louapre, Céline; Lubetzki, Catherine // Multiple Sclerosis Journal;Nov2015, Vol. 21 Issue 13, p1626 

    The article discusses debates about the causes of neurodegeneration in multiple sclerosis (MS), a type of central nervous system (CNS) inflammatory disease. Topics discussed include how inflammation and neurodegeneration interplay over the disease course, the potential factors that influence...

  • Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis. Tenorio-Laranga, Jofre; Coret-Ferrer, Francisco; Casanova-Estruch, Buenaventura; Burgal, María; García-Horsman, J. Arturo // Journal of Neuroinflammation;2010, Vol. 7, p23 

    Background: Multiple sclerosis (MS) is a complex, inflammatory and neurodegenerative disease of the central nervous system leading to long-term disability. Recent studies indicate a close association between inflammation and neurodegeneration in all lesions and disease stages of MS. Prolyl...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics